ESR1 and rheumatoid arthritis: Leflunomide, an immunosuppressive disease-modifying anti-rheumatic drug whose efficacy is modulated by ESR1 gene polymorphisms [55], is the only drug identified with a direct use in active moderate to severe rheumatoid arthritis.